TransEnterix, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for fulfilling their surgical needs.
“Five single-port swine laparoscopic cholecystectomy procedures were completed in sterile conditions, and all animals survived for 1 week postoperatively.”
“‘Proof of Principle Prototype 1’ or ‘PoPP1’ shall mean the completion of the design, Design Review, fabrication and testing (including Animal Testing) of the first iteration of FSP Product prototypes.”
TransEnterix, Inc. operates as a development stage medical device company. The company is focused on the development and commercialization of SurgiBot™, a novel patient side minimally invasive surgical robotic system. It uses instruments and robotics to improve the outcomes of minimally invasive surgery. TransEnterix was founded in August 19, 1988 and is headquartered in Morrisville, NC. [Source: MarketWatch]